[HTML][HTML] Gout epidemiology and comorbidities

JA Singh, A Gaffo - Seminars in arthritis and rheumatism, 2020 - Elsevier
Objective To review the epidemiology of gout and associated comorbidities. Methods We
review the key published studies of the epidemiology of gout and associated comorbidities …

2016 updated EULAR evidence-based recommendations for the management of gout

P Richette, M Doherty, E Pascual, V Barskova… - Annals of the …, 2017 - ard.bmj.com
Background New drugs and new evidence concerning the use of established treatments
have become available since the publication of the first European League Against …

2018 updated European League Against Rheumatism evidence-based recommendations for the diagnosis of gout

P Richette, M Doherty, E Pascual, V Barskova… - Annals of the …, 2020 - ard.bmj.com
Although gout is the most common inflammatory arthritis, it is still frequently misdiagnosed.
New data on imaging and clinical diagnosis have become available since the first EULAR …

[HTML][HTML] Междисциплинарные клинические рекомендации «Лечение ожирения и коморбидных заболеваний»

ИИ Дедов, МВ Шестакова… - Ожирение и …, 2021 - cyberleninka.ru
Клинические рекомендации уже давно вошли в число рабочих инструментов
современного врача, помогая ему быстро ориентироваться в наиболее эффективных …

Global epidemiology of gout: prevalence, incidence and risk factors

CF Kuo, MJ Grainge, W Zhang, M Doherty - Nature reviews …, 2015 - nature.com
Gout is a crystal-deposition disease that results from chronic elevation of uric acid levels
above the saturation point for monosodium urate (MSU) crystal formation. Initial presentation …

[HTML][HTML] The British Society for Rheumatology guideline for the management of gout

M Hui, A Carr, S Cameron, G Davenport… - …, 2017 - academic.oup.com
Gout is the most common cause of inflammatory arthritis worldwide. In UK general practice,
the overall prevalence has increased from 1.4% in 1999 to 2.49% in 2012 [1], despite the …

2012 American College of Rheumatology guidelines for management of gout. Part 1: systematic nonpharmacologic and pharmacologic therapeutic approaches to …

D Khanna, JD Fitzgerald, PP Khanna… - Arthritis care & …, 2012 - Wiley Online Library
Gout is a disorder that manifests as a spectrum of clinical and pathologic features built on a
foundation of an excess body burden of uric acid, manifested in part by hyperuricemia …

Epidemiology of gout

E Roddy, HK Choi - Rheumatic Disease Clinics, 2014 - rheumatic.theclinics.com
Gout is a crystal deposition disease that arises when supersaturation of body tissues with
urate occurs, leading to the formation of monosodium urate (MSU) crystals in and around …

Gout. Epidemiology of gout

E Roddy, M Doherty - Arthritis research & therapy, 2010 - Springer
Gout is the most prevalent form of inflammatory arthropathy. Several studies suggest that its
prevalence and incidence have risen in recent decades. Numerous risk factors for the …

Relationship between serum urate concentration and clinically evident incident gout: an individual participant data analysis

N Dalbeth, A Phipps-Green, C Frampton… - Annals of the …, 2018 - ard.bmj.com
Objectives To provide estimates of the cumulative incidence of gout according to baseline
serum urate. Methods Using individual participant data from four publicly available cohorts …